Work after brain injury, daily walking, family priorities and a neck-pain trial—plus guidance, education and a seed recall.
Radu Physiatry editorial desk · About 14 minutes · AI-assisted, source-checked; not physician-reviewed
A leather purse, a wooden bench, an engraving task and an inventory: these were actual assignments in a Swiss rehabilitation workshop, not a fictional patient's story. Researchers used them to observe how people after traumatic brain injury managed instructions, competing tasks and rules over several hours. A quiet examination room can answer important questions about cognition. A working day places different demands on it.
That difference runs through today's edition. A work-focused assessment detects difficulties without becoming an employability verdict. An exercise study measures walking outside the clinic. A pediatric questionnaire asks parents which activities matter, while a neck-pain trial examines whether a longer treatment session changes the result. Each helps connect a measurement to the life rehabilitation is meant to support.
These four reports and a stroke co-design study were published October 8. An encephalitis guideline appears in an October 2026 issue, but its exact publication day was not verified. Established workplace guidance and a future education programme are dated separately. The safety desk covers an October 8 seed recall. No physician review has been recorded for this edition.
Brain injury and vocational rehabilitation · Exploratory psychometric study · Main full report and Tables 1–3 reviewed · Published October 8, 2026
A work task can reveal what a test score leaves out
The Swiss study compared 50 adults with traumatic brain injury receiving return-to-work rehabilitation with 40 controls from musculoskeletal rehabilitation. The Multiple Errands Test in a Professional Setting, or MET-PRO, combined vocational tasks, information gathering and rules in a workshop. It examined the management of activity as well as whether tasks were finished.
Forty-one of fifty participants with brain injury, or 82%, failed at least one MET-PRO score. Among 23 who succeeded on the study's overall traditional cognitive assessment, 16, or about 70%, nevertheless failed MET-PRO. This suggests that a structured test and a prolonged work-like activity can reveal different difficulties. It does not establish that every person who performs well in a clinic has a hidden impairment.
The control finding matters just as much: 14 of 40 controls, or 35%, also failed at least one score. A single result outside the control range was enough for the overall assessment to be labelled failed. The useful clinical information may therefore be the pattern of errors—such as difficulty applying rules or completing assignments—rather than a binary pass or fail.
Clinical notes: ecological assessment is not an employability verdict
MET-PRO had limited association with return to work. Of 38 participants with complete follow-up information, 16 returned to work. Follow-up occurred about twelve months after testing, not twelve months after the injury. Neither passing nor failing the workshop assessment determined the eventual work outcome.
This was an exploratory study at one centre, with no advance formal sample-size calculation. Participants had to tolerate at least four hours of vocational activity; severe physical disability that interfered with testing was excluded. Most participants were men. The findings are not a prevalence estimate for all people with brain injury.
Controls were recruited earlier than the brain-injury group and differed in educational level. The same control sample helped establish the thresholds; this is not independent validation of diagnostic sensitivity and specificity. With several scores, defining failure as any abnormal score creates multiple opportunities to cross a threshold. A 95th-percentile cutoff for each score does not guarantee 95% specificity for the entire battery.
Scoring calibration involved only five patient protocols and led to refinement of the scoring procedure. It should not be presented as a definitive reliability study. Missing work follow-up and the many noncognitive influences on employment further limit prediction. The appropriate use is to inform an individual assessment of tasks, fatigue, supports and workplace demands. Supplements and raw participant data were not independently appraised.
Established guidance · NICE NG252, published October 15, 2025 · Actual workplace recommendations reviewed
The job itself belongs in the assessment
NICE's workplace recommendations for chronic neurological disorders ask clinicians to consider retained skills, strengths and motivation, discuss work early, and identify barriers with the person and relevant workplace professionals. Vocational assessment and rehabilitation should use an appropriate setting, which may include the workplace, clinic, community or home.
The guidance also calls for checking whether workplace adjustments work and reviewing them when rehabilitation needs change. It asks how the person wants adjustments explained to colleagues and what information should remain confidential. These are established recommendations, not a new October 9 guideline.
The connection to MET-PRO is our clinical interpretation: observing a difficulty should lead to a question about support, rather than an automatic conclusion that work is impossible. A task may need different instructions, pacing or supervision; the suitability of an adjustment needs assessment. We reviewed section 1.23, not the entire guideline or its underlying evidence reviews.
Older adults and musculoskeletal rehabilitation · Secondary analysis of a randomized trial · Abstract only · Published October 8, 2026
Taking a longer step is different from taking more steps
Fifty-nine community-dwelling adults aged at least 65, with mild to moderate knee or low-back pain, were randomized to a twelve-week exercise programme using videos and staff assistance or an educational control. An ankle sensor measured walking during two planned seven-day observation windows. This was an analysis of walking in daily life, rather than only performance during a clinic test.
The modified intention-to-treat analysis included 52 people and 696 repeated observations. The estimated between-group step-length effect was +2.39 cm (P = .04; Hedges g = 0.493). Walking speed had a smaller, statistically uncertain signal: +0.05 m/s (P = .06). Daily steps, distance, cadence and the reported activity-volume measures showed no clear between-group difference.
A change in how someone walks is not automatically a change in how much that person walks. For a patient, useful follow-up questions are whether walking feels easier and whether it supports the activities that matter. This analysis does not show that the programme prevented falls, increased community participation or increased daily step count.
Clinical notes: repeated observations do not create hundreds of participants
The 696 observations come from repeated measurements in 52 people, not 696 independently randomized patients. The statistical model needs to account for that structure. Two observation windows also do not provide continuous measurement throughout twelve weeks.
In the 44-person per-protocol sensitivity analysis, the estimated step-length effect was +1.95 cm (P = .13), and the speed effect was +0.04 m/s (P = .14). The direction was similar, but precision was insufficient to establish those differences. These analyses answer related questions in different subsets; selecting whichever P value is smallest would obscure uncertainty.
The authors describe attenuation after considering multiple outcomes and sensitivity analyses. The abstract does not provide confidence intervals for the walking coefficients, detailed missing-data methods or enough information to independently reproduce those analyses. A P value of .04 is not a guarantee of an important or durable benefit. The intervention also combined videos with staff assistance, so its effect cannot be assigned to the video component alone. Full-text retries returned no usable content.
Pediatric rehabilitation and outcome measurement · Reliability study · Abstract only · Published October 8, 2026
Ask the family what needs to become easier
The Canadian Occupational Performance Measure, or COPM, helps identify activity problems and rate performance and satisfaction. A study examined the Arabic version through interviews with 100 parents of children with physical disabilities. Thirty parents repeated the assessment after fourteen days.
Interrater intraclass correlations were 0.84 for performance and 0.80 for satisfaction; test-retest values were 0.83 and 0.91, respectively. Agreement on which problems were prioritized was 73%. These findings concern the consistency of measurement. They do not test whether using the questionnaire makes treatment more effective.
The parent interview can put daily activities into a rehabilitation conversation. A practical clinical question is whether the same priority remains important at the next visit, and how the child and family experience any change. Those are our interpretive questions, not a reproduction of the instrument or a claim that parent ratings capture every aspect of the child's experience.
Clinical notes: reliability, agreement and meaningful change
A high intraclass correlation indicates consistency relative to variation in this sample; it does not mean two raters always assign identical scores or select identical priorities. The reported performance-score limits of agreement were −1.69 to +1.60 points on the ten-point scale. They describe variation between measurements, not a threshold for clinically important improvement.
Reliability, responsiveness to treatment and clinical importance are separate measurement properties. A stable instrument can still require additional evidence before an individual change is interpreted as meaningful. Prioritization agreement and agreement on problem categories also answer different questions; the abstract reports only slight-to-fair interrater agreement for categories.
This was a convenience sample and a parent-proxy assessment, with only thirty people in the repeat-testing subset. Confidence intervals for the intraclass correlations and full procedures were unavailable for appraisal. The results support further use and evaluation in the studied context, without establishing universal validity across ages, diagnoses, languages or settings. Full article access remained unavailable after retries.
Musculoskeletal pain · Assessor-blinded randomized trial · Main full report and actual Table 4 reviewed · Published October 8, 2026
Five extra minutes need their own evidence
A Thai trial randomized 66 adults aged 18–55 with chronic upper-trapezius myofascial pain to ten or fifteen minutes of repetitive peripheral magnetic stimulation, once weekly for four weeks. Both groups received stretching and ergonomic education. Both protocols included the same five-minute targeted phase; the longer protocol extended the scanning phase around it.
At week four, the adjusted pain-score difference, ten-minute minus fifteen-minute protocol, was −0.27, 95% CI −0.95 to +0.40 (P = .43). The neck-disability difference was −0.64 points, 95% CI −3.29 to +2.02 (P = .64). The study did not detect an advantage from the longer duration.
Both groups improved, but the randomized comparison was between two active programmes. There was no sham or stretching-only group. Consequently, this trial cannot isolate how much improvement came from magnetic stimulation, background exercise, expectations or other influences. It also did not measure whether shorter sessions improve access or cost effectiveness.
Clinical notes: superiority is not equivalence, and units need checking
The trial used a superiority design. It did not prespecify an equivalence or noninferiority margin. A confidence interval crossing zero and a nonsignificant P value do not establish that the two durations are equivalent, or that ten minutes is a proven optimum.
The report's methods describe measuring a 100-mm visual analogue line, while the results and Table 4 report VAS “scores” without clearly explaining rescaling. We reproduce the between-group estimate as reported and do not convert it into millimetres or assert a clinically important pain-point difference. The 0.5-point difference used for sample-size planning was explicitly a design assumption, not an established clinical-importance threshold.
Twelve participants lacked week-four assessments. The main mixed-effects analysis included all randomized participants and assumed data were missing at random; multiple-imputation sensitivity analysis reportedly produced consistent findings. That assumption remains an assumption, even when logistical reasons for missed visits are plausible.
No serious adverse events or treatment-related discontinuations were reported. Selected patients, four-week follow-up and a small sample limit conclusions about safety and durability. The main report and actual between-group table were appraised; supplements, raw data and earlier sham-controlled studies cited by the authors were not independently reviewed.
Guidance watch · EAN/ESCMID adult infectious encephalitis guideline · October 2026 journal issue · Primary abstract only
The acute neurological pathway still matters
The European guideline abstract reports two formal recommendations: initiate intravenous aciclovir as soon as possible when encephalitis is suspected, and do not replace pathogen-specific cerebrospinal-fluid PCR testing with multiplex panels. It reports thirteen additional good-practice statements and no recommendation for or against corticosteroids in proven herpes-simplex encephalitis.
These are clinician-directed acute-care recommendations, not self-treatment instructions. The distinction between evidence-based recommendations and good-practice statements matters for board study. We could not obtain the full guideline after retries, so diagnostic algorithms, treatment dosing, rehabilitation statements and the underlying evidence were not appraised. The exact publication day remains unverified; a newly indexed abstract is not proof of an October 9 publication.
Education desk · Stroke co-design report published October 8, 2026 · Actual ASRA programme listings checked October 9
Engagement is something to design with people
A stroke-rehabilitation co-design study gathered perspectives from thirty participants: nine stroke survivors, eleven clinicians and ten science knowledge-users. Eighteen participants later refined the strategies. The authors developed ten engagement strategies for in-person, subacute upper-limb rehabilitation, emphasizing personalization through timing and emphasis.
No intervention was delivered, and feasibility remains to be tested. Co-design establishes a proposed approach, not proof of improved function or attendance. The primary abstract was reviewed; the full strategy list was unavailable. For learners, our suggested exercise is to ask when an explanation or prompt would be helpful to the person, rather than assuming that more instruction always produces more engagement.
ASRA's actual listings for its November 5–7, 2026 meeting in Tampa include sessions on opioid safety, pain ultrasonography, neuromodulation and persistent perioperative pain. This is a future education lead, not completed course content or a new treatment recommendation. Its guide states that workshops and problem-based discussions require advance registration and an additional fee. We reviewed the listings, not paid lectures. This magazine grants no CME or official examination credit.
Product safety · Company announcement and FDA posting October 8, 2026
A seed recall to check in the kitchen
Gardeners Basics recalls Waltham 29 Broccoli Sprouting Seeds in one-pound white-and-green pouches, UPC 848137042889, marked “Packed for 2027”, because of possible Salmonella contamination. The notice says to stop using the seeds, not eat them or sprouts grown from them, and seal both in a bag for disposal. No return is required; contact the company for recall assistance or a refund.
The announcement reports no related illnesses known to the company as of October 6. That does not exclude contamination or establish safety. Product identity matters: these instructions concern the recalled bags. Frail older adults and people with weakened immunity are among the groups the notice identifies as vulnerable to serious infection.
A work-task assessment defines abnormal performance using the 95th percentile for each of several error scores. A person fails the whole assessment if any score is abnormal. In its control sample, 35% fail at least one score. Which interpretation is best supported?
The whole assessment necessarily has 95% specificity.
Failure proves the person cannot return to work.
Multiple scores create several opportunities for a threshold crossing; the pattern and clinical context need interpretation.
Passing a traditional cognitive test makes further functional assessment unnecessary.
Reveal answer and explanation
C. A per-score cutoff does not determine the false-positive proportion of a combined “any score” rule. Correlations between scores and how thresholds were derived also matter. The control results require caution, and this exploratory study did not validate the test as an employability verdict. This is an original educational question grounded in the cited MET-PRO report, not an official examination item.
The small glossary
Ecological assessment
Assessment that places abilities in realistic daily or work-like demands, rather than relying only on isolated tasks.
Executive function
Skills used to plan, manage goals, adapt strategies, monitor actions and apply rules.
Psychometric study
A study of how an assessment measures something, including its consistency, agreement or relationship to other measures.
Modified intention-to-treat
An analysis that keeps a defined subset of randomized participants; the exclusions and their consequences need checking.
Per-protocol analysis
An analysis of participants meeting specified treatment or assessment requirements, who may differ from those excluded.
Intraclass correlation (ICC)
A measure of consistency relative to differences among people in a sample. It is not the percentage of exactly matching scores.
Limits of agreement
A range describing differences expected between measurements under the studied conditions.
Missing at random
A statistical assumption that missingness can be explained by observed information used in the analysis, rather than unobserved outcomes alone.
Noninferiority margin
A prespecified limit on how much worse a treatment could be while still meeting a noninferiority claim.
PCR
Polymerase chain reaction: a method for detecting genetic material, including material from infectious pathogens.
The practical takeaway: combine measurements with an understanding of the person's actual activities. A test can identify a difficulty without deciding a future, and a consistent score does not prove treatment benefit. Name the goal, examine the comparison and uncertainty, and revisit whether the plan works at home, in the community or at work.
Four research reports, one guideline abstract and one stroke co-design study were appraised. The MET-PRO main report and Tables 1–3, and the magnetic-stimulation trial main report plus actual Table 4, were read in full. Supplements, raw data and earlier studies cited by the authors were not independently appraised. Daily-walking and Arabic-COPM reports, the EAN/ESCMID encephalitis guideline and stroke co-design study were reviewed through primary PubMed abstracts; retries did not provide their full content. The encephalitis publication day remains unverified beyond its October 2026 issue. Actual NICE NG252 workplace recommendations 1.23, ASRA future meeting session listings and registration conditions, and the Gardeners Basics FDA-posted recall announcement were separately read. Other guideline sections, underlying evidence reviews, licensed chapters, paid course content and source transcripts were not appraised. Stroke journal discovery recovered on retry; the original failed scan is preserved privately and final coverage records its recovery. No physician review has been recorded. This is independent education, not accredited CME or official examination material.
The discovery window was 2026/09/09–2026/10/09. A journal index check can miss work not yet indexed. A retrieved landing page does not verify every linked publication, paid course, podcast or textbook chapter. Candidate counts are discovery records, not validated practice changes.
Educational, not medical advice. Discuss treatment choices with your clinician. Sources and evidence evolve; each dated edition preserves what was checked for that issue.